Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Borde

Showing results (691-700 of 700) with videos related to

Pageof 70
Sort By:
You have reached the last page of results.This site can display upto 700 results.
Journal of Medical Genetics|April 14, 2019
Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883)Jan Hauke, Eric Hahnen, Stephanie Schneider, et al.
Breast Cancer Research : BCR|January 26, 2018
BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancerNana Weber-Lassalle, Jan Hauke, Juliane Ramser, et al.
Journal of Cardiothoracic and Vascular Anesthesia|April 2, 2026
Digital Stethoscope-Derived Single-Lead Electrocardiogram and Artificial Intelligence to Detect Low Ejection Fraction: A Multicenter Observational StudyDeepak Prakash Borde, Shreedhar Joshi, Kumar Chidambaram, et al.
Journal of the American Society of Nephrology : JASN|April 7, 2017
Clinical and Genetic Spectrum of Bartter Syndrome Type 3Elsa Seys, Olga Andrini, Mathilde Keck, et al.
International Journal of Neonatal Screening|April 3, 2021
Neonatal Screening in Europe Revisited: An ISNS Perspective on the Current State and Developments Since 2010J Gerard Loeber, Dimitris Platis, Rolf H Zetterström, et al.
Cancer Medicine|March 10, 2018
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian CancerJan Hauke, Judit Horvath, Eva Groß, et al.
Global Biogeochemical Cycles|June 23, 2025
Blue Carbon Stocks Along the Pacific Coast of North America Are Mainly Driven by Local Rather Than Regional FactorsChristopher N Janousek, Johannes R Krause, Judith Z Drexler, et al.
British Journal of Cancer|June 20, 2019
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriersFrank Qian, Matti A Rookus, Goska Leslie, et al.
Communications Biology|October 6, 2022
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriersChristopher Hakkaart, John F Pearson, Louise Marquart, et al.
Cancer Research|November 15, 2019
Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and AggressivenessVivek L Patel, Evan L Busch, Tara M Friebel, et al.
Pageof 70

Showing results (691-700 of 700) with videos related to

Sort By:
Pageof 70
You have reached the last page of results.This site can display upto 700 results.
Journal of Medical Genetics|April 14, 2019
Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883)Jan Hauke, Eric Hahnen, Stephanie Schneider, et al.
Breast Cancer Research : BCR|January 26, 2018
BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancerNana Weber-Lassalle, Jan Hauke, Juliane Ramser, et al.
Journal of Cardiothoracic and Vascular Anesthesia|April 2, 2026
Digital Stethoscope-Derived Single-Lead Electrocardiogram and Artificial Intelligence to Detect Low Ejection Fraction: A Multicenter Observational StudyDeepak Prakash Borde, Shreedhar Joshi, Kumar Chidambaram, et al.
Journal of the American Society of Nephrology : JASN|April 7, 2017
Clinical and Genetic Spectrum of Bartter Syndrome Type 3Elsa Seys, Olga Andrini, Mathilde Keck, et al.
International Journal of Neonatal Screening|April 3, 2021
Neonatal Screening in Europe Revisited: An ISNS Perspective on the Current State and Developments Since 2010J Gerard Loeber, Dimitris Platis, Rolf H Zetterström, et al.
Cancer Medicine|March 10, 2018
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian CancerJan Hauke, Judit Horvath, Eva Groß, et al.
Global Biogeochemical Cycles|June 23, 2025
Blue Carbon Stocks Along the Pacific Coast of North America Are Mainly Driven by Local Rather Than Regional FactorsChristopher N Janousek, Johannes R Krause, Judith Z Drexler, et al.
British Journal of Cancer|June 20, 2019
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriersFrank Qian, Matti A Rookus, Goska Leslie, et al.
Communications Biology|October 6, 2022
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriersChristopher Hakkaart, John F Pearson, Louise Marquart, et al.
Cancer Research|November 15, 2019
Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and AggressivenessVivek L Patel, Evan L Busch, Tara M Friebel, et al.
Pageof 70